Oncoxx Biotech (Oncoxx) is an SME (small-medium enterprise) founded in 2012, that collaborates with top representatives of medical and experimental oncology at the National and International level.
Oncoxx is grounded on key IP assets, such as the PCT/ international patents WO2010089782, US 8,715,662, EU 2009787638, CN102448492A, AU2009339664B, CA2750038.
Mission of Oncoxx is to synergize with Mediterranea Theranostic, to extend its activities and value at a global scale as an independent SME.
To this end, top-level consultants have been enrolled for business propositions in the EU, US and Asia.
The company gathers some of the best oncologists from the southern Italy. One of the main expertise of the company is related with the scientific supervision of the I, II and IIIrd stage clinical trials with reference to both diagnostics and human cancer therapeutics.
The company relies on the facilities and cutting-edge equipment provided by collaborating Academic Labs.